With respect to BMSC lysates, MIP-1α levels showed lower trends in the Treg-CM group compared to BMSC alone at day 0 and Non-CM, while G-CSF levels were significantly reduced in BMSC treated with OM and Treg-CM compared to BMSC alone at day 0 (Fig. 7f). The gene discussed is CSF3; the disease is ocular melanoma.